OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
October 02, 2020
Misleading messages contribute to eroding trust in public health agencies.
European pharma companies may have a vested interest in the outcome of the US elections.
September 02, 2020
AstraZeneca has potentially taken poll position in the race to develop a novel coronavirus vaccine, but will AZD1222 be ready in 2020?
Amid high expectations for a vaccine, bio/pharma readies capacity, weighs pressures.
August 02, 2020
Time sure flies, except when you are waiting for something to happen.
COVID-19’s impact on the global economy is dealing a blow to merger and acquisition activity in the biopharma industry.
July 02, 2020
FDA Commissioner Hahn commits to a science-based review and approval process.
April 02, 2020
As the coronavirus pandemic unfolds, Pharma must practice science over hype.
As COVID-19 rapidly spreads, the bio/pharma industry is committing significant efforts to fast track development of therapies.
March 02, 2020
Despite increasing R&D budgets by bio/pharma companies, returns on this investment are reducing and the cost of bringing an asset to market is increasing.